Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Urology. 2011 Nov;78(5):1101-6. doi: 10.1016/j.urology.2011.05.012. Epub 2011 Sep 8.
To characterize the incidence and clinicopathologic factors associated with late recurrence after surgical resection for renal cell carcinoma (RCC) because the recurrence patterns >5 years after nephrectomy have been poorly described.
We identified 1454 patients treated with nephrectomy for localized RCC from 1970 to 2000 who had remained free of disease for 5 years. Subsequent tumor recurrence was classified as renal recurrence and distant metastasis. The incidence of recurrence >5 years from surgery was estimated using the Kaplan-Meier method. The associations of clinicopathologic variables with late recurrence were analyzed using Cox proportional hazard regression models.
With a median postoperative follow-up of 13.9 years (range 5.1-38.9), 63 patients (4.3%) experienced late renal recurrence at a median of 9.3 years (range 5.1-25.3), and 172 patients (11.8%) developed late distant metastases at a median of 9.6 years (range 5.1-26.6) after surgery. The estimated recurrence-free survival rate at 10 and 15 years was 97.3% and 95.2% for renal recurrence, and 93.1% and 85.9% for distant metastases, respectively. On multivariate analysis, increased tumor size (hazard ratio [HR] 1.12; P < .001) was associated with late renal tumor recurrence, and increased tumor size (HR 1.07; P = .018), clear cell or collecting duct histologic features (HR 3.76; P < .001), and tumor Stage pT1b (HR 2.8; P < .001), pT2a (HR 4.5; P < .001), pT2b (HR 3.4; P = .007), and pT3-pT4 (HR 5.1; P < .001) were associated with distant metastasis.
After an initial 5-year postoperative disease-free interval, approximately 5% and 15% of patients will develop renal recurrence and distant metastases, respectively, during the next decade. Therefore, long-term surveillance remains necessary after nephrectomy.
描述肾细胞癌(RCC)切除术后晚期复发的发生率和临床病理特征,因为术后 5 年以上的复发模式描述较差。
我们从 1970 年至 2000 年期间,确定了 1454 例接受肾切除术治疗局限性 RCC 的患者,这些患者在 5 年内无疾病。随后的肿瘤复发分为肾复发和远处转移。使用 Kaplan-Meier 方法估计手术后 5 年以上的复发发生率。使用 Cox 比例风险回归模型分析临床病理变量与晚期复发的相关性。
中位术后随访 13.9 年(范围 5.1-38.9),63 例(4.3%)患者在中位时间 9.3 年(范围 5.1-25.3)后出现晚期肾复发,172 例(11.8%)患者在中位时间 9.6 年(范围 5.1-26.6)后发生远处转移。10 年和 15 年的无复发生存率分别为肾复发的 97.3%和 95.2%,远处转移的 93.1%和 85.9%。多变量分析显示,肿瘤大小增加(风险比 [HR] 1.12;P<0.001)与晚期肾肿瘤复发相关,肿瘤大小增加(HR 1.07;P=0.018)、透明细胞或集合管组织学特征(HR 3.76;P<0.001)和肿瘤分期 pT1b(HR 2.8;P<0.001)、pT2a(HR 4.5;P<0.001)、pT2b(HR 3.4;P=0.007)和 pT3-pT4(HR 5.1;P<0.001)与远处转移相关。
在最初的 5 年无病术后间隔后,接下来的 10 年内,大约 5%和 15%的患者将分别发生肾复发和远处转移。因此,肾切除术后仍需长期监测。